| Dr Michael Motolko, MD | |
|
618 Toll Gate Rd, Warwick, RI 02886-2717 | |
| (401) 737-0981 | |
| (401) 732-4931 |
| Full Name | Dr Michael Motolko |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 618 Toll Gate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497815930 | NPI | - | NPPES |
| 7006310 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD9709 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Motolko, MD 566 Toll Gate Rd, Warwick, RI 02886-2716 Ph: (401) 738-4800 | Dr Michael Motolko, MD 618 Toll Gate Rd, Warwick, RI 02886-2717 Ph: (401) 737-0981 |
News Archive
Those who lost coverage because insurers canceled their plans have been given a hardship exemption through October 2016 from the requirement to have health insurance or pay a fine, Fox News reports. Other stories look at rising medical identity theft and the frustration of a cancer survivor who enrolled in a plan based on misinformation that her doctor was included in its network.
The Food and Drug Administration today has taken a critically important action to protect the American public from tobacco industry deception by warning several manufacturers – most prominently Reynolds American's subsidiary, Santa Fe Natural Tobacco Company, and its Natural American Spirit cigarette brand – that they are violating the law by marketing their products with health-related claims, including "additive-free" and "natural." If these products continue to make these claims, the FDA can and should order them removed from the market.
Exposure to targeted, personal and verbal aggression by patients can adversely affect mental health nurses decision-making regarding physical restraint, new research published in the world's leading nursing research journal reveals.
A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.
› Verified 2 days ago
Dr. Leah Lynn Kammerdiener, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-5183 | |
Barbara Dodsworth-feldman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 618 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-0231 | |
Dr. Tatyana Serednyakova, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-8153 | |
Dr. Michael O'brien, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-8153 | |
Dr. William F. Varr Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 220 Toll Gate Rd, Warwick, RI 02886 Phone: 401-732-6640 Fax: 401-739-5265 | |
Theresa Marie Tretter, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-8153 |